Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J U Gutterman

Showing results (311-320 of 333) with videos related to

Pageof 34
Sort By:
Cancer|March 1, 1978
Intensive postoperative chemoimmunotherapy for patients with stage II and stage III breast cancerA U Buzdar, J U Gutterman, G R Blumenschein, et al.
Journal of Surgical Oncology|December 1, 1979
Chemoimmunotherapy with or without oophorectomy in premenopausal patients with advanced breast cancerH Y Yap, G N Hortobagyi, G R Blumenschein, et al.
Archives of Internal Medicine|December 1, 1976
Developmental therapy in adult acute leukemiaE J Freireich, G P Bodey, K B McCredie, et al.
Cancer Treatment Reports|January 1, 1980
Chemoimmunotherapy for metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, methotrexate, L-asparaginase, Corynebacterium parvum, and Pseudomonas vaccineG N Hortobagyi, H Y Yap, C L Wiseman, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|June 1, 1995
Recombinant human retinoblastoma protein inhibits cancer cell growthL C Pagliaro, D Antelman, D E Johnson, et al.
Journal of Surgical Oncology|January 1, 1979
Adjuvant chemoimmunotherapy following regional therapy for isolated recurrences of breast cancer (stage IV NED)A U Buzdar, G R Blumenschein, T L Smith, et al.
Annals of the New York Academy of Sciences|January 1, 1984
Immunologic studies of the acquired immune deficiency syndrome: relationship of immunodeficiency to extent of diseaseE M Hersh, J M Reuben, P W Mansell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
Phase I trial of liposomal muramyl tripeptide phosphatidylethanolamine in cancer patientsJ L Murray, E S Kleinerman, J E Cunningham, et al.
Annals of the New York Academy of Sciences|January 1, 1976
Immunocompetence, immunodeficiency and prognosis in cancerE M Hersh, J U Gutterman, G M Mavligit, et al.
Cancer Research|April 1, 1977
Phase 2 study with Baker's Antifol in solid tumorsV Rodriguez, S P Richman, R S Benjamin, et al.
Pageof 34

Showing results (311-320 of 333) with videos related to

Sort By:
Pageof 34
Cancer|March 1, 1978
Intensive postoperative chemoimmunotherapy for patients with stage II and stage III breast cancerA U Buzdar, J U Gutterman, G R Blumenschein, et al.
Journal of Surgical Oncology|December 1, 1979
Chemoimmunotherapy with or without oophorectomy in premenopausal patients with advanced breast cancerH Y Yap, G N Hortobagyi, G R Blumenschein, et al.
Archives of Internal Medicine|December 1, 1976
Developmental therapy in adult acute leukemiaE J Freireich, G P Bodey, K B McCredie, et al.
Cancer Treatment Reports|January 1, 1980
Chemoimmunotherapy for metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, methotrexate, L-asparaginase, Corynebacterium parvum, and Pseudomonas vaccineG N Hortobagyi, H Y Yap, C L Wiseman, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|June 1, 1995
Recombinant human retinoblastoma protein inhibits cancer cell growthL C Pagliaro, D Antelman, D E Johnson, et al.
Journal of Surgical Oncology|January 1, 1979
Adjuvant chemoimmunotherapy following regional therapy for isolated recurrences of breast cancer (stage IV NED)A U Buzdar, G R Blumenschein, T L Smith, et al.
Annals of the New York Academy of Sciences|January 1, 1984
Immunologic studies of the acquired immune deficiency syndrome: relationship of immunodeficiency to extent of diseaseE M Hersh, J M Reuben, P W Mansell, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1989
Phase I trial of liposomal muramyl tripeptide phosphatidylethanolamine in cancer patientsJ L Murray, E S Kleinerman, J E Cunningham, et al.
Annals of the New York Academy of Sciences|January 1, 1976
Immunocompetence, immunodeficiency and prognosis in cancerE M Hersh, J U Gutterman, G M Mavligit, et al.
Cancer Research|April 1, 1977
Phase 2 study with Baker's Antifol in solid tumorsV Rodriguez, S P Richman, R S Benjamin, et al.
Pageof 34